Literature DB >> 11988243

Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study.

Maria Giovanna Marrosu1, Eleonora Cocco, Marina Lai, Gabriella Spinicci, Maria Paola Pischedda, Paolo Contu.   

Abstract

BACKGROUND: Individuals from Sardinia, Italy, are at high risk of developing multiple sclerosis and type 1 diabetes mellitus. We attempted to assess the prevalence in this region of type 1 diabetes mellitus in individuals with multiple sclerosis, and to ascertain disease risk factors.
METHODS: We did a cohort study to assess prevalence of type 1 diabetes in 1090 people with multiple sclerosis, and in their parents (n=2180) and siblings (n=3300), all born and living in Sardinia. All participants were patients at the multiple sclerosis clinic in Cagliari, and were judged representative of the total Sardinian outpatients and inpatients. We asked patients whether their parents or siblings had multiple sclerosis or diabetes, confirming replies by examining clinical records. We identified risk factors for diabetes with univariate and multivariate logistic regression analyses.
FINDINGS: Diabetes prevalence in people with multiple sclerosis was, respectively, about three-fold and five-fold that in their healthy siblings (p=0.001) and in the general population (p<0.0001). Presence of other relatives with multiple sclerosis conferred increased risk of type 1 diabetes to healthy siblings of individuals with multiple sclerosis (odds ratio=3.41, p=0.0019). Diabetes risk was six-fold higher in patients with relatives having multiple sclerosis than in healthy siblings of multiple sclerosis patients without other relatives with the disease (p=0.0001).
INTERPRETATION: In Sardinian families with genetic inheritance of multiple sclerosis type 1 diabetes is prevalent, both in multiple sclerosis patients and in healthy siblings. This finding indicates that common genes contribute to susceptibility to both diseases in this population.

Entities:  

Mesh:

Year:  2002        PMID: 11988243     DOI: 10.1016/S0140-6736(02)08431-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  Epidemiology of autoimmune diseases in Denmark.

Authors:  William W Eaton; Noel R Rose; Amanda Kalaydjian; Marianne G Pedersen; Preben Bo Mortensen
Journal:  J Autoimmun       Date:  2007-06-19       Impact factor: 7.094

Review 2.  Type 1 diabetes mellitus and multiple sclerosis: common etiological features.

Authors:  Adam E Handel; Lahiru Handunnetthi; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Endocrinol       Date:  2009-11-03       Impact factor: 43.330

3.  Multiple sclerosis and autoimmune diseases: epidemiology and HLA-DR association in North-east Italy.

Authors:  Alice Laroni; Massimiliano Calabrese; Paola Perini; Maria Paola Albergoni; Federica Ranzato; Michela Tiberio; Leontino Battistin; Paolo Gallo
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

4.  Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI study.

Authors:  Lorena Lorefice; Giuseppe Fenu; Roberta Pitzalis; Giulia Scalas; Jessica Frau; Giancarlo Coghe; Luigina Musu; Vincenzo Sechi; Maria Antonietta Barracciu; Maria Giovanna Marrosu; Eleonora Cocco
Journal:  J Neurol       Date:  2018-03-05       Impact factor: 4.849

5.  Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis.

Authors:  R Zivadinov; B Raj; M Ramanathan; B Teter; J Durfee; M G Dwyer; N Bergsland; C Kolb; D Hojnacki; R H Benedict; B Weinstock-Guttman
Journal:  AJNR Am J Neuroradiol       Date:  2016-02-18       Impact factor: 3.825

6.  Comorbidities at multiple sclerosis diagnosis.

Authors:  Agnès Fromont; Christine Binquet; Fabien Rollot; Romain Despalins; Alain Weill; Laurence Clerc; Claire Bonithon-Kopp; Thibault Moreau
Journal:  J Neurol       Date:  2013-08-02       Impact factor: 4.849

Review 7.  Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.

Authors:  Ruth Dobson; Gavin Giovannoni
Journal:  J Neurol       Date:  2013-01-12       Impact factor: 4.849

8.  TRPV1 gates tissue access and sustains pathogenicity in autoimmune encephalitis.

Authors:  Geoffrey Paltser; Xue Jun Liu; Jason Yantha; Shawn Winer; Hubert Tsui; Ping Wu; Yuko Maezawa; Lindsay S Cahill; Christine L Laliberté; Sreeram V Ramagopalan; Gabriele C DeLuca; A Dessa Sadovnick; Igor Astsaturov; George C Ebers; R Mark Henkelman; Michael W Salter; H-Michael Dosch
Journal:  Mol Med       Date:  2013-07-24       Impact factor: 6.354

9.  HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.

Authors:  L F Barcellos; J R Oksenberg; A B Begovich; E R Martin; S Schmidt; E Vittinghoff; D S Goodin; D Pelletier; R R Lincoln; P Bucher; A Swerdlin; M A Pericak-Vance; J L Haines; S L Hauser
Journal:  Am J Hum Genet       Date:  2003-01-28       Impact factor: 11.025

Review 10.  The immunogenetics of multiple sclerosis.

Authors:  Arne Svejgaard
Journal:  Immunogenetics       Date:  2008-05-07       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.